Homing Neural Stem Cells Deliver Direct Cancer Treatment
By Patrick Yang ’20 With average survival for glioblastoma patients at approximately 12-15 months, speed is of essence for glioblastoma cancer treatment. Currently, promising stem cell research has found that neural stem cells naturally migrate towards the chemical signals released by glioblastoma cells. If these neural stem cells are engineered to contain cytotoxic agents, they can deliver cancer treatment directly to cancer cells. However, the … Continue reading Homing Neural Stem Cells Deliver Direct Cancer Treatment

